Human-AI Collaboration: Paradigm Shifts in Technology-Mediated Design
Art Sciences · 2025
DOI: 10.70267/as202502020108 ↗Kurz gefasst
Fachartikel in der Zeitschrift Art Sciences, 2025. Verfasst von Xu Zhang und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The rapid advancement of artificial intelligence (AI) is catalyzing a transformative paradigm shift in design. Beyond altering designers' workflows, AI is reshaping the very foundations of creative processes and enabling new forms of human-AI collaboration. This study examines technology-mediated design innovations through empirical case analyses, elucidating AI's role in advancing the field and redefining collaborative dynamics between humans and intelligent systems. Key findings reveal that AI enhances design efficacy through three principal mechanisms: automation, personalization, and intelligent optimization-collectively contributing to improved productivity, creativity, and user engagement. Nevertheless, these technological strides present emergent challenges, notably the evolving professional identity of designers, the reconfiguration of creative agency, and unresolved ethical dilemmas. By critically evaluating the capabilities and limitations of human-AI collaboration, this work provides design scholars and practitioners with a balanced perspective on the opportunities and risks of technology-mediated design innovation.
Zitieren
APA
Zhang, X., & Zhou, Y. (2025). Human-AI Collaboration: Paradigm Shifts in Technology-Mediated Design. Art Sciences. https://doi.org/10.70267/as202502020108
Vancouver
Zhang X, Zhou Y. Human-AI Collaboration: Paradigm Shifts in Technology-Mediated Design. Art Sciences. 2025. doi:10.70267/as202502020108
BibTeX
@article{Zhang2025,
author = {Zhang, Xu and Zhou, Yixuan},
title = {Human-AI Collaboration: Paradigm Shifts in Technology-Mediated Design},
journal = {Art Sciences},
year = {2025},
doi = {10.70267/as202502020108}
}
EUVIMED